why choose us

First received: October 07, 2024

Clinical Trial: A Phase 2 Study of JNT-517 in Adolescent Participants With Phenylketonuria

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Phenylketonuria (PKU)

Study Type: INTERVENTIONAL


Official Title: A Phase 2 Study of JNT-517 in Adolescent Participants With Phenylketonuria

Brief Summary: The goal of this Phase 2, randomized study is to assess the safety, tolerability, and pharmacokinetics (PK) of oral JNT-517 in adolescents (12 to less than 18 years of age) with PKU. Participants will receive either JNT-517 or placebo and will be blinded to their treatment assignment. Participants will have a 4 in 5 (or 80%) chance of receiving JNT-517. The study will last for up to 63 days including a Screening period, Treatment period and Follow-up period for safety.Participants will:* Take 75 mg JNT-517 or a…

Read more